Overview

Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death

Status:
Terminated
Trial end date:
2011-04-01
Target enrollment:
0
Participant gender:
All
Summary
Recent ACC/AHA/ESC guidelines recommend prophylactic ICD implantation in most patients with coronary heart disease and LVEF < 40%. Current Canadian guidelines recommend ICDs for primary prophylaxis in CAD patients with LVEF < 30% (Class I recommendation). There are very sparse data to recommend ICD implantation in patients with EF between 30 and 40 %. This study will randomize patients with CHD and an EF between 30 and 40% to ICD therapy vs. No ICD therapy. The primary outcome is mortality and the study is powered as a non-inferiority trial to test the hypothesis that mortality in patients with no ICD is not more than 1% greater (absolute yearly increase) than patients receiving an ICD.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
St. Michael's Hospital, Toronto
Unity Health Toronto
Collaborators:
Institute for Clinical Evaluative Sciences
Ontario Ministry of Health and Long Term Care
Criteria
Inclusion Criteria:

- documented chronic coronary heart disease (prior MI and/or angiographically documented
CAD), > 40 days post the most recent MI;

- LVEF < 40% (by MUGA) and NYHA functional class II or III at time of assessment OR LVEF
≤ 35 % (by MUGA) and NYHA functional class I, II or III at time of assessment

- Judged to have a reasonable expectation of survival with a good functional status for
more than 1 year, as well as receiving optimum, guideline recommended therapy for
coronary artery disease and heart failure (or demonstrated intolerance or
contraindications to such therapy).

- Age ≥ 18 years; no upper age limitation.

Exclusion Criteria:

- Prior cardiac arrest, sustained VT or VF, or unexplained syncope.

- Attempted VT / VF induction at electrophysiological study.

- Need for a cardiac resynchronization therapy (CRT) device.

- Enrollment in another interventional trial.